• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,138.37CD20 down 0.16 percent0.16%BTC$77,067.98BTC down 0.23 percent0.23%ETH$2,381.34ETH down 1.29 percent1.29%XRP$1.35XRP up 0.17 percent0.17%SOL$99.65SOL up 0.0056 percent0.0056%
Prices > ABT
ABTABT
$110.47Up 1.41 percent, +$1.541.41%($1.54)
As of today at 4:00 PM ET

Key Stats

Volume (24h)6,803,069
Day's Range$108.71-$112.18

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Website
abbott.com
Industry
PHARMACEUTICAL PREPARATIONS
Full-time Employees
115,000
Headquarters
ABBOTT PARK
IPO Date
Apr 19, 1949
Loading chart...
PE Ratio208.43
EPS0.53
Net Income (FY)$6.52B
Revenue (FY)$44.33B
Market Cap$190.965B

Similar Stocks

S
S&P 500 ETFSPY
$765.12
Up 0.44 percent0.44%($3.34)
BullishBLSH
$32.64
Down 1.27 percent1.27%($0.42)
Coinbase Global IncCOIN
$174.88
Down 1.10 percent1.10%($1.94)
Circle Internet GroupCRCL
$88.67
Down 0.91 percent0.91%($0.81)
52-Week Range$81.97-$137.49
24 hours5 days1 monthYTD1 yearAll time
Up 1.41 percent1.41%
Down 1.00 percent1.00%
Up 4.51 percent4.51%
Down 12.17 percent12.17%
Down 16.73 percent16.73%
—

Latest ABT News

If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio
4 hrs agoPositive
(opens in a new tab)

If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio

7 hrs agoPositive(opens in a new tab)

If I Could Only Buy and Hold 1 Dividend ETF Forever, Here's What I'd Choose

12 hrs agoNeutral(opens in a new tab)

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

2 days agoPositive(opens in a new tab)

National Advertising Division Finds Certain Kendamil Infant Formula Claims Supported; Recommends Others Be Modified or Discontinued

2 days agoPositive(opens in a new tab)

Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

6 days agoNeutral(opens in a new tab)

Abbott (ABT) Stock Sinks As Market Gains: Here's Why

6 days agoPositive(opens in a new tab)

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight